E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/4/2014 in the Prospect News PIPE Daily.

Tauriga Sciences takes in $900,000 through private placement of stock

Offer sells 15 million shares to fund working capital, debt repayment

By Devika Patel

Knoxville, Tenn., April 4 - Tauriga Sciences, Inc. settled a $900,000 private placement of stock from March 31 through April 3, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 15 million common shares at $0.06 apiece, which is identical to the closing share price on March 28.

Proceeds will be used for working capital purposes and to repay promissory notes.

The Danbury, Conn., company develops the next generation immunotherapies to treat cancer.

Issuer:Tauriga Sciences, Inc.
Issue:Common stock
Amount:$900,000
Shares:15 million
Price:$0.06
Warrants:No
Settlement date:March 31 through April 3
Stock symbol:OTCBB: TAUG
Stock price:$0.06 at close March 28
Market capitalization:$40.27 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.